Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 0 | 18,036 | 41 | 49 |
| Gross Profit | N/A | N/A | 18,036 | 41 | 49 |
| Operating Expenses | 46,282 | 4,064 | 63,889 | 37,669 | 31,739 |
| Operating Income | -46,282 | -4,064 | -45,853 | -37,628 | -31,690 |
| Interest Expense | 0 | 0 | 2,930 | 1,932 | 2,052 |
| Other Income | -205 | -5 | 1,527 | 632 | 265 |
| Pre-tax Income | -46,487 | -4,069 | -47,256 | -38,928 | -33,477 |
| Income Tax | N/A | N/A | 1,699 | 1 | 1 |
| Net Income Continuous | -46,487 | -4,069 | -48,955 | -38,929 | -33,478 |
| Net Income | $-46,487 | $-4,069 | $-48,955 | $-38,929 | $-33,478 |
| EPS Basic Total Ops | -158.00 | -48.25 | -914.54 | -997.00 | -5,704.65 |
| EPS Basic Continuous Ops | -157.93 | -48.26 | -914.75 | -998.84 | -5,703.63 |
| EPS Diluted Total Ops | -158.00 | -48.25 | -914.54 | -997.00 | -5,704.65 |
| EPS Diluted Continuous Ops | -157.93 | -48.26 | -914.75 | -998.84 | -5,703.63 |
| EPS Diluted Before Non-Recurring Items | -158.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-46,228 | $-4,053 | $-45,476 | $-37,355 | $-31,444 |